Annette Kleiser
Amministratore Delegato presso Dalan Animal Health, Inc.
Posizioni attive di Annette Kleiser
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Dalan Animal Health, Inc.
 Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/12/2018 | - |
Storia della carriera di Annette Kleiser
Precedenti posizioni note di Annette Kleiser
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALLON THERAPEUTICS INC. | Corporate Officer/Principal | 27/08/2007 | 01/09/2008 |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Formazione di Annette Kleiser
| Universität Konstanz | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 3 |
| Stati Uniti | 3 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dalan Animal Health, Inc.
Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Health Technology |
- Borsa valori
- Insiders
- Annette Kleiser
- Esperienza
